Biography and Research Information
OverviewAI-generated summary
Ahmad Mazen Safar's research focuses on the molecular mechanisms and predictive factors in cancer treatment. He has investigated the role of proliferation-related genes as indicators for adjuvant therapy in colon cancer, with findings published in 2025. His work also explores the validity of mutations as a method for tracking cancer progression over time, as detailed in a 2022 publication. Safar has also contributed to research on immune oncology, specifically examining the early discontinuation of treatment in stage IV non-small cell lung cancer patients monitored through C-reactive protein levels, a study published in 2021.
Safar collaborates with researchers at the University of Arkansas for Medical Sciences, including Jim Zhongning Chen, Farhan Kawsar, Nishanth Thalambedu, and Ples Spradley. His scholarship metrics include an h-index of 1, with a total of 6 publications and 5 citations.
Metrics
- h-index: 1
- Publications: 6
- Citations: 5
Selected Publications
-
Role of proliferation-related genes as predictive factors for adjuvant therapy in colon cancer. (2025)
-
Validity of mutations as a cancer chronometer. (2022)
-
Monitoring C-reactive protein facilitates early discontinuation of immune oncology without compromising outcomes in stage IV non-small cell lung cancer. (2021)
Collaboration Network
Top Collaborators
- Validity of mutations as a cancer chronometer.
- Role of proliferation-related genes as predictive factors for adjuvant therapy in colon cancer.
- Monitoring C-reactive protein facilitates early discontinuation of immune oncology without compromising outcomes in stage IV non-small cell lung cancer.
- Monitoring C-reactive protein facilitates early discontinuation of immune oncology without compromising outcomes in stage IV non-small cell lung cancer.
- Validity of mutations as a cancer chronometer.
- Role of proliferation-related genes as predictive factors for adjuvant therapy in colon cancer.
- Role of proliferation-related genes as predictive factors for adjuvant therapy in colon cancer.
- Role of proliferation-related genes as predictive factors for adjuvant therapy in colon cancer.
Similar Researchers
Based on overlapping research topics